688506 百利天恒
已收盘 04-30 15:00:01
资讯
新帖
简况
百利天恒（688506）2025年一季报简析：净利润减110.62%，三费占比上升明显
证券之星 · 04-30 22:41
百利天恒（688506）2025年一季报简析：净利润减110.62%，三费占比上升明显
百利天恒截止03月31日股东人数4585.00户，人均持股2.01万股
市场透视 · 04-30 07:49
百利天恒截止03月31日股东人数4585.00户，人均持股2.01万股
百利天恒04月30日遭主力抛售503.4万元
市场透视 · 04-30 07:21
百利天恒04月30日遭主力抛售503.4万元
百利天恒跌4.55% 8家券商推荐
智选洞察 · 04-30 01:30
百利天恒跌4.55% 8家券商推荐
百利天恒一季度亏损5.31亿元，同比下降110.6%
财中社 · 04-29
百利天恒一季度亏损5.31亿元，同比下降110.6%
图解百利天恒一季报：第一季度单季净利润同比减110.62%
证券之星 · 04-29
图解百利天恒一季报：第一季度单季净利润同比减110.62%
百利天恒最新公告：一季度净亏损5.31亿元
证券之星 · 04-29
百利天恒最新公告：一季度净亏损5.31亿元
百利天恒：一季度净利润亏损5.31亿元
澎湃新闻 · 04-29
百利天恒：一季度净利润亏损5.31亿元
百利天恒涨3.01% 基因药获批
智选洞察 · 04-29
百利天恒涨3.01% 基因药获批
A股创新药概念股震荡走强，博瑞医药涨超10%，创4年新高，艾迪药业、康辰药业涨超6%，诺思兰德、百利天恒、荣昌生物、君实
美港电讯 · 04-28
A股创新药概念股震荡走强，博瑞医药涨超10%，创4年新高，艾迪药业、康辰药业涨超6%，诺思兰德、百利天恒、荣昌生物、君实
百利天恒1082.07万股限售股将于4月28日解禁，占总股本2.7%
证券之星 · 04-28
百利天恒1082.07万股限售股将于4月28日解禁，占总股本2.7%
百利天恒04月25日主力净流出1615万元 散户资金买入
市场透视 · 04-25
百利天恒04月25日主力净流出1615万元 散户资金买入
百利天恒大跌3.36% 近半年8家券商买入
智选洞察 · 04-25
百利天恒大跌3.36% 近半年8家券商买入
AACR即将开幕，医药或迎密集催化
Ofweek维科网 · 04-24
AACR即将开幕，医药或迎密集催化
百利天恒股价迭创新高 券商看好后市表现：核心管线有望年内申报上市，多个在研项目获临床进展
每日经济新闻 · 04-23
百利天恒股价迭创新高 券商看好后市表现：核心管线有望年内申报上市，多个在研项目获临床进展
一季度提高两只医药基金股票仓位，中欧基金葛兰加仓科伦药业、百利天恒
澎湃新闻 · 04-22
一季度提高两只医药基金股票仓位，中欧基金葛兰加仓科伦药业、百利天恒
百利天恒：BL-M11D1(CD33-ADC)联合用药治疗新诊断的急性髓系白血病获得药物临床试验批准通知书
格隆汇 · 04-22
百利天恒：BL-M11D1(CD33-ADC)联合用药治疗新诊断的急性髓系白血病获得药物临床试验批准通知书
百利天恒04月22日主力净流入1189万元 散户资金抛售
市场透视 · 04-22
百利天恒04月22日主力净流入1189万元 散户资金抛售
A股午后医药板块持续走高，创新药方向继续领涨，众生药业、华森制药、富士莱涨停，百利天恒、诺诚健华、新诺威、百济神州创历史
美港电讯 · 04-22
A股午后医药板块持续走高，创新药方向继续领涨，众生药业、华森制药、富士莱涨停，百利天恒、诺诚健华、新诺威、百济神州创历史
A股创新药板块震荡走高，华纳药厂涨超10%，热景生物涨超7%，东诚药业、百利天恒、翰宇药业跟涨。
美港电讯 · 04-22
A股创新药板块震荡走高，华纳药厂涨超10%，热景生物涨超7%，东诚药业、百利天恒、翰宇药业跟涨。
加载失败，点击重试
公司概况
公司名称：
四川百利天恒药业股份有限公司
所属行业：
医药制造业
上市日期：
2023-01-06
主营业务：
四川百利天恒药业股份有限公司的主营业务是创新生物药业务板块和化药制剂、中成药制剂业务板块。公司的主要产品是丙泊酚乳状注射液、丙泊酚中/长链脂肪乳注射液、吸入用七氟烷、中/长链脂肪乳注射液、结构脂肪乳注射液(C6~24)、黄芪颗粒、盐酸胍法辛缓释片。
发行价格：
24.70
{"stockData":{"symbol":"688506","market":"SH","secType":"STK","nameCN":"百利天恒","latestPrice":286.08,"timestamp":1745996401000,"preClose":289.15,"halted":0,"volume":1117369,"delay":0,"changeRate":-0.0106,"floatShares":103000000,"shares":401000000,"eps":-4.5614,"marketStatus":"已收盘","change":-3.07,"latestTime":"04-30 15:00:01","open":276,"high":290.02,"low":274,"amount":317000000,"amplitude":0.0554,"askPrice":286.5,"askSize":0,"bidPrice":286.08,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-4.5614,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"adjPreClose":289.15,"symbolType":"stock_kcb","openAndCloseTimeList":[[1745976600000,1745983800000],[1745989200000,1745996400000]],"highLimit":318.07,"lowLimit":260.24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":401000000,"isCdr":false,"pbRate":34.03,"roa":"--","roe":"--","epsLYR":9.25,"committee":0.52381,"marketValue":114718000000,"turnoverRate":0.0109,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-05-06。","afterMarket":{"amount":0,"volume":0,"close":286.08,"buyVolume":0,"sellVolume":0,"time":1745998438029,"indexStatus":"已收盘 04-30 15:30:00","preClose":289.15},"floatMarketCap":29435000000},"requestUrl":"/m/hq/s/688506/tweets","defaultTab":"tweets","newsList":[{"id":"2532938018","title":"百利天恒（688506）2025年一季报简析：净利润减110.62%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2532938018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532938018?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:41","pubTimestamp":1746052915,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期百利天恒发布2025年一季报。截至本报告期末，公司营业总收入6744.0万元，同比下降98.77%，归母净利润-5.31亿元，同比下降110.62%。本报告期百利天恒三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达8183.26%。答：2024年内，公司实现营业收入582,271.78万元，同比增长936.31%，归属于上市公司股东的净利润370,750.46万元，较上年同期增加448,800.34万元，实现扭亏为盈。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100004890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688506"],"gpt_icon":0},{"id":"2531083810","title":"百利天恒截止03月31日股东人数4585.00户，人均持股2.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531083810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531083810?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:49","pubTimestamp":1745999399,"startTime":"0","endTime":"0","summary":"百利天恒披露公司股东人数最新情况，截止2025年03月31日，公司股东人数为4585.00户，较上期减少52户，环比减少1.12%。人均持仓股环比增长情形用户持仓来看，百利天恒人均持仓2.01万股，上期人均持仓1.99万股，环比增长1.01%，户均持股趋向集中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165851a46d7073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165851a46d7073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2531083812","title":"百利天恒04月30日遭主力抛售503.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531083812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531083812?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:21","pubTimestamp":1745997679,"startTime":"0","endTime":"0","summary":"04月30日, 百利天恒股价跌1.06%，报收286.08元，成交金额3.2亿元，换手率1.09%，振幅5.54%，量比0.95。百利天恒今日主力资金净流出503.4万元，连续4日净流出，上一交易日主力净流出727.0万元。该股近5个交易日上涨0.91%，主力资金累计净流出3333.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1147.6万元，其中净流入天数为8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430164517a6ce910e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430164517a6ce910e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506"],"gpt_icon":0},{"id":"2531574237","title":"百利天恒跌4.55% 8家券商推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2531574237","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531574237?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:30","pubTimestamp":1745976603,"startTime":"0","endTime":"0","summary":"04月30日，百利天恒股价大幅下跌，截至09点30分，百利天恒下跌4.55%，报276.00元/股，成交397万元，换手率0.01%。资金动向截止发稿，百利天恒获得主力净流入45万元，其中超大单流入41万元，大单流入4万元。主营业务及业绩百利天恒公司主营业务为药品的研发、生产及销售。最新财报显示，今年一季报，百利天恒实现营业收入6,744.00万元，同比减少98.77%，净利润为-5.31亿元，同比减少110.62%，基本每股收益为-1.33元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430093406a46cf067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430093406a46cf067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2531731521","title":"百利天恒一季度亏损5.31亿元，同比下降110.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531731521","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531731521?lang=zh_cn&edition=full","pubTime":"2025-04-29 20:58","pubTimestamp":1745931483,"startTime":"0","endTime":"0","summary":"4月29日，百利天恒公布2025年一季报，公司营业收入为6744万元，同比下降98.8%；归母净利润亏损5.31亿元，同比下降110.6%；扣非归母净利润亏损5.57亿元，同比下降111.1%；经营现金流净额为-4.9亿元，同比下降109.1%；EPS为-1.3253元。报告显示，研发投入合计达到4.95亿元，占营业收入的比例为733.86%。尽管本报告期内营业收入大幅下降至6744万元，但公司仍然保持了积极的研发活动，努力推动创新和产品的市场化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042920583094e79076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042920583094e79076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506"],"gpt_icon":0},{"id":"2531871337","title":"图解百利天恒一季报：第一季度单季净利润同比减110.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531871337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531871337?lang=zh_cn&edition=full","pubTime":"2025-04-29 19:58","pubTimestamp":1745927897,"startTime":"0","endTime":"0","summary":"证券之星消息，百利天恒2025年一季报显示，公司主营收入6744.0万元，同比下降98.77%；归母净利润-5.31亿元，同比下降110.62%；扣非净利润-5.57亿元，同比下降111.14%；负债率54.68%，财务费用-3188.09万元，毛利率49.35%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900037815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688506"],"gpt_icon":0},{"id":"2531207997","title":"百利天恒最新公告：一季度净亏损5.31亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531207997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531207997?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:10","pubTimestamp":1745921408,"startTime":"0","endTime":"0","summary":"百利天恒(688506.SH)公告称，公司2025年一季度营业收入为6744万元，同比下降98.77%，主要系上年同期确认了大额知识产权授权收入。一季度净亏损5.31亿元，去年同期净利润50.05亿元，主要系营业收入减少和研发费用增加。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900035839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2531786574","title":"百利天恒：一季度净利润亏损5.31亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531786574","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531786574?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:01","pubTimestamp":1745920860,"startTime":"0","endTime":"0","summary":"4月29日，四川百利天恒药业股份有限公司（百利天恒，688506.SH）披露一季报，2025年第一季度营业收入为6744万元，同比下降98.77%；归属于上市公司股东的净利润亏损5.31亿元，上年同期净利润50.05亿元，主要系报告期内营业收入同比大幅减少、研发费用有所增加所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291802049749f725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291802049749f725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506"],"gpt_icon":0},{"id":"2531214239","title":"百利天恒涨3.01% 基因药获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2531214239","media":"智选洞察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531214239?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:13","pubTimestamp":1745892810,"startTime":"0","endTime":"0","summary":"消息解读4月上旬，我国首个基因替代疗法药物“信玖凝”获国家药品监督管理局批准上市，用于治疗中重度血友病B成年患者。此前，全球只有8款rAAV基因治疗药物获批上市。主营业务及业绩百利天恒公司主营业务为药品的研发、生产及销售。最新财报显示，今年年报，百利天恒实现营业收入58.23亿元，同比增长936.31%，净利润为37.08亿元，同比增长575.02%，基本每股收益为9.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910140797495a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910140797495a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2530909604","title":"A股创新药概念股震荡走强，博瑞医药涨超10%，创4年新高，艾迪药业、康辰药业涨超6%，诺思兰德、百利天恒、荣昌生物、君实","url":"https://stock-news.laohu8.com/highlight/detail?id=2530909604","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530909604?lang=zh_cn&edition=full","pubTime":"2025-04-28 11:06","pubTimestamp":1745809591,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["06978","LU1969619763.USD","01877","BK0239","LU1064130708.USD","399300","09995","LU1064131003.USD","159992","688331","BK1574","159982","603590","BK1161","LU2148510915.USD","688180","BK1583","LU2328871848.SGD","BK1515","BK0262","688506","688488","688166"],"gpt_icon":0},{"id":"2530460536","title":"百利天恒1082.07万股限售股将于4月28日解禁，占总股本2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530460536","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530460536?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:04","pubTimestamp":1745798663,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，百利天恒于4月28日将有1082.07万股限售股份解禁，为公司首发原股东限售股份，占公司总股本2.7%。最近一年内，该股累计解禁161.94万股，占总股本的0.4%。本次解禁后，公司还有2.98亿股限售股份，占总股本74.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428081519a469ace5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428081519a469ace5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2530977483","title":"百利天恒04月25日主力净流出1615万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2530977483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530977483?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:22","pubTimestamp":1745565763,"startTime":"0","endTime":"0","summary":"04月25日, 百利天恒股价跌2.16%，报收276.90元，成交金额2.94亿元，换手率1.16%，振幅5.12%，量比1.08。百利天恒今日主力资金净流出1615万元，上一交易日主力净流入1314万元。该股近5个交易日上涨6.91%，主力资金累计净流入2187万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1.30亿元，其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164312a6c7c6d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164312a6c7c6d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2530694851","title":"百利天恒大跌3.36% 近半年8家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2530694851","media":"智选洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530694851?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:33","pubTimestamp":1745544820,"startTime":"0","endTime":"0","summary":"04月25日，百利天恒股价大幅下跌，截至09点33分，百利天恒下跌3.36%，报273.50元/股，成交2416万元，换手率0.09%，振幅3.71%。资金动向截止发稿，百利天恒获得主力净流入125万元，其中超大单流出13万元，大单流入139万元。主营业务及业绩百利天恒公司主营业务为药品的研发、生产及销售。最新财报显示，今年年报，百利天恒实现营业收入58.23亿元，同比增长936.31%，净利润为37.08亿元，同比增长575.02%，基本每股收益为9.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042509360194e1bd38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042509360194e1bd38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506"],"gpt_icon":0},{"id":"2529462576","title":"AACR即将开幕，医药或迎密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2529462576","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529462576?lang=zh_cn&edition=full","pubTime":"2025-04-24 11:19","pubTimestamp":1745464762,"startTime":"0","endTime":"0","summary":"AACR将于当地时间4月25日至4月30日在美国费城召开，本次会议将有近100家中国药企亮相，带来超200项新药研究结果。恒瑞医药、科伦博泰、信达生物、百利天恒、再鼎医药、复宏汉霖、乐普生物等有望发布重要ADC数据，涉及诸多靶点，中国ADC技术有望在国际舞台崭露头角。近年来，国内创新药在AACR会议上的影响力持续攀升，ADC之外，双抗及小分子疗法市场关注度也较高，或带来更多消息面的催化，恒生医药ETF已连续5日上涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688566","688658","600488","600196","BK0183","600664","688506","603351","688247","BK0060","600267","601089","600216","603669","BK0012","600521","600420","688578","159938","BK0196","603676","605507","BK0188","605116","600789","688602","600062","600380","BK0096","BK0187","603538","688505","688799","BK0028","688091","688166","BK0175","688076","BK0239","600812","603367"],"gpt_icon":0},{"id":"2529639707","title":"百利天恒股价迭创新高 券商看好后市表现：核心管线有望年内申报上市，多个在研项目获临床进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2529639707","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529639707?lang=zh_cn&edition=full","pubTime":"2025-04-23 23:18","pubTimestamp":1745421506,"startTime":"0","endTime":"0","summary":"截至4月23日收盘，百利天恒股价报收于283.50元，市值站稳千亿元大关。记者注意到，今年内，百利天恒核心管线BL-B01D1有望在国内申报上市，并有望于今年上半年启动首个海外III期临床。百利天恒股价屡创新高，券商看好后市增长空间4月22日，百利天恒股价创历史新高。截至当日收盘，百利天恒上涨11.41%，报收于291.51元，最高价创近一年新高，换手率1.41%，成交量129.89万股，成交额3.62亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042323191194dfc456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042323191194dfc456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506"],"gpt_icon":0},{"id":"2529877815","title":"一季度提高两只医药基金股票仓位，中欧基金葛兰加仓科伦药业、百利天恒","url":"https://stock-news.laohu8.com/highlight/detail?id=2529877815","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529877815?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:33","pubTimestamp":1745332380,"startTime":"0","endTime":"0","summary":"4月22日，中欧基金投资总监葛兰在管基金披露了2025年一季报。其中，科伦药业首次进入该基金的持仓前十。拉长时间来看，中欧医疗健康于2018年清仓卖出科伦药业之后，又于2024年重新买回。此外，葛兰还小幅度加仓了泰格医药、爱尔眼科。截至2025年一季度末，该基金在管规模为82亿元，较此前2024年末增长10.17亿元，是葛兰旗下规模第二大的基金产品。展望二季度，葛兰仍旧看好创新药持续突破、消费医疗复苏与产业链关键环节国产化等方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422224124a46299e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422224124a46299e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","LU2148510915.USD","LU1064130708.USD","LU1064131003.USD","688506","160635","002422","BK0239"],"gpt_icon":0},{"id":"2529237323","title":"百利天恒：BL-M11D1(CD33-ADC)联合用药治疗新诊断的急性髓系白血病获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2529237323","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529237323?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:57","pubTimestamp":1745312225,"startTime":"0","endTime":"0","summary":"格隆汇4月22日丨百利天恒公布，近日收到国家药品监督管理局正式批准签发的《药物临床试验批准通知书》，公司自主研发的创新生物药注射用BL-M11D1联合用药的药物临床试验获得批准。BL-M11D1是与BL-B01D1出自同一技术平台、与BL-B01D1共享同一“连接子+毒素”平台的靶向CD33的ADC药物。截至目前，除本次新获得批准的临床试验外，BL-M11D1正在国内进行Ib期临床试验，并在美国同步进行I期临床试验，适应症为复发或难治性急性髓系白血病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042217021294dddf70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042217021294dddf70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688506"],"gpt_icon":0},{"id":"2529340182","title":"百利天恒04月22日主力净流入1189万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529340182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529340182?lang=zh_cn&edition=full","pubTime":"2025-04-22 15:21","pubTimestamp":1745306491,"startTime":"0","endTime":"0","summary":"04月22日, 百利天恒股价涨11.41%，报收291.51元，成交金额3.62亿元，换手率1.41%，振幅14.85%，量比1.22。百利天恒今日主力资金净流入1189万元，上一交易日主力净流出2770万元。该股近5个交易日上涨12.47%，主力资金累计净流出2385万元；近20日主力资金累计净流入1.06亿元，其中净流入天数为9日。|04月22日主力加仓幅度排名||#|股票简称|主力净额占比|#|亚联机械|7.81%|#|华鹏飞|7.50%|#|泰禾股份|6.23%|#|...|...|#1215|百利天恒|0.04%|百利天恒所在的化学制药行业，今日主力净流出3.03亿元，行业排名32/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422163119a4622d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422163119a4622d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","BK0239"],"gpt_icon":0},{"id":"2529701316","title":"A股午后医药板块持续走高，创新药方向继续领涨，众生药业、华森制药、富士莱涨停，百利天恒、诺诚健华、新诺威、百济神州创历史","url":"https://stock-news.laohu8.com/highlight/detail?id=2529701316","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529701316?lang=zh_cn&edition=full","pubTime":"2025-04-22 13:47","pubTimestamp":1745300842,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0196","BK0077","BK0239","399300","09969","BK1191","688235","BK1515","LU1969619763.USD","01349","ONC","159938","159982","300765","BK1161","BK1588","002294","002317","BK1574","LU2328871848.SGD","BK0226","301258","09939","BK1500","BK1583","BK0183","06160","LU0307460666.USD","BK0187","LU0588546209.SGD","BK0188","688091","BK4139","688068","688505","688428","002907","159992","06978","688506","BK0028"],"gpt_icon":0},{"id":"2529395377","title":"A股创新药板块震荡走高，华纳药厂涨超10%，热景生物涨超7%，东诚药业、百利天恒、翰宇药业跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529395377","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529395377?lang=zh_cn&edition=full","pubTime":"2025-04-22 10:40","pubTimestamp":1745289614,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["06978","BK0077","BK0028","BK0188","399300","BK0070","688799","BK0239","688068","002675","BK1161","300199","688506","159992","BK1574","159982"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746221229290,"stockEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.2315},{"period":"3month","weight":0.4836},{"period":"6month","weight":0.5355},{"period":"1year","weight":0.8497},{"period":"ytd","weight":0.4921}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0087},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0217}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川百利天恒药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4585人(较上一季度减少1.12%)","perCapita":"22440股","listingDate":"2023-01-06","address":"四川省成都市温江区成都海峡两岸科技产业园百利路161号一幢一号","registeredCapital":"40100万元","survey":" 四川百利天恒药业股份有限公司的主营业务是创新生物药业务板块和化药制剂、中成药制剂业务板块。公司的主要产品是丙泊酚乳状注射液、丙泊酚中/长链脂肪乳注射液、吸入用七氟烷、中/长链脂肪乳注射液、结构脂肪乳注射液(C6~24)、黄芪颗粒、盐酸胍法辛缓释片。","listedPrice":24.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百利天恒(688506)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百利天恒(688506)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百利天恒,688506,百利天恒股票,百利天恒股票老虎,百利天恒股票老虎国际,百利天恒行情,百利天恒股票行情,百利天恒股价,百利天恒股市,百利天恒股票价格,百利天恒股票交易,百利天恒股票购买,百利天恒股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百利天恒(688506)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百利天恒(688506)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}